Thymol and carvacrol alleviate diarrhea in goat kids by remodeling the gut microbiota and enhancing mucin-associated barrier responses
Аннотация
Background Although thymol and carvacrol (CAT) have been shown to alleviate diarrhea in 3-month-old Tibetan cashmere goat kids, it remains unclear whether CAT exert these effects by remodeling the intestinal microbiota and modulating metabolite-associated mucin responses. Results Here, we established an acute E. coli O157:H7 challenge-associated intestinal disturbance model in 3-month-old goat kids by intraperitoneal injection and used integrated multi-omics analyses to investigate the effects of CAT. CAT treatment significantly remodeled the intestinal microbiota, reduced the abundance of E. coli , and enriched the potential commensal bacterium Romboutsia maritimum . Metabolomic analysis showed that CAT significantly increased benzyl cinnamate (BzC), which was positively correlated with R. maritimum and IL-10. Genome-based functional annotation indicated that R. maritimum harbors genes annotated to phenylpropanoid-related pathways, suggesting predicted metabolic potential that may be associated with BzC-related metabolism. In parallel, proteomic analysis revealed that CAT upregulated proteins involved in mucin-type O-glycosylation in intestinal epithelial tissues, with GALNT7 identified as a key responsive protein. Functional assays further demonstrated that BzC promoted MUC2 expression in a GALNT7-dependent manner, thereby supporting mucin-associated barrier responses and attenuating diarrhea-related intestinal alterations. Conclusions These findings identify a potential microbiota–metabolite regulatory pathway by which CAT protects against intestinal inflammation in young goat kids and provide new insights into microbiota-based strategies for controlling diarrhea in young ruminants.